Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Trisenox now available in Canada

Nov. 14, 2013

Canadian approval for Eylea in wet AMD

Nov. 14, 2013

Health Canada approves Opsumit for pulmonary arterial hypertension

Nov. 14, 2013

Health Canada approves Giotrif

Nov. 8, 2013

Health Canada approves Stivarga for gastrointestinal stromal tumors

Oct. 21, 2013

Jublia approved in Canada for the treatment of onychomycosis

Oct. 4, 2013

Bayer receives Canadian approval for riociguat in thromboembolic pulmonary hypertension

Sep. 26, 2013

Health Canada approves Roche's Erivedge for advanced basal cell carcinoma

Aug. 28, 2013

Jetrea approved for symptomatic vitreomacular adhesion in Canada

Aug. 19, 2013

Health Canada approves two GSK drugs for metastatic melanoma

July 25, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...